Treatment-induced hypoxia attenuates enzalutamide response and promotes resistance in pre-clinical models of prostate cancer.

^*Corresponding author for this work

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Publication status	Published - 10 Sept 2017
Event	ESMO Congress 2017: Integrating science into oncology for a better patient outcome - Madrid, Spain Duration: 08 Sept 2017 → 12 Sept 2017 http://www.esmo.org/Conferences/Past-Conferences/ESMO-2017-Congress

Conference	ESMO Congress 2017
Country/Territory	Spain
City	Madrid
Period	08/09/2017 → 12/09/2017
Internet address	http://www.esmo.org/Conferences/Past-Conferences/ESMO-2017-Congress

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@conference{6e20ec4d9bb04293be0529aaa0f5ee50,

title = "Treatment-induced hypoxia attenuates enzalutamide response and promotes resistance in pre-clinical models of prostate cancer.",

author = "Pamela Maxwell and David Waugh and {LaBonte Wilson}, Melissa",

year = "2017",

month = sep,

day = "10",

language = "English",

note = "ESMO Congress 2017 : Integrating science into oncology for a better patient outcome ; Conference date: 08-09-2017 Through 12-09-2017",

url = "http://www.esmo.org/Conferences/Past-Conferences/ESMO-2017-Congress",

}